| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |